Clinical significance of CTC enumeration on the Epic Sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients treated with AR signaling inhibitors (ARSi) Meeting Abstract
| Authors: | Schonhoft, J.; Gill, A.; Graf, R. P.; Jendrisak, A.; Barnett, E.; Benoliel, H.; Carbone, E.; Tubbs, A.; Orr, S.; Byun, J.; Wenstrup, R.; Scher, H. I. |
| Abstract Title: | Clinical significance of CTC enumeration on the Epic Sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients treated with AR signaling inhibitors (ARSi) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368302414 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.5571 |
| Notes: | Meeting Abstract: 5571 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
